Isolated glycerol kinase deficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:408OMIM:307030E74.8
Who is this for?
Show terms as
1FDA treatments8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Isolated glycerol kinase deficiency (GKD), also known as hyperglycerolemia, is a rare X-linked metabolic disorder caused by mutations in the GK gene located on chromosome Xp21.2. Glycerol kinase is an enzyme that catalyzes the phosphorylation of glycerol to glycerol-3-phosphate, a key step in fat metabolism and gluconeogenesis. When this enzyme is deficient, glycerol accumulates in the blood (hyperglycerolemia) and is excreted in excess in the urine (glyceroluria). The condition primarily affects males, while females are typically carriers who may occasionally show mild symptoms. Isolated GKD presents with a wide clinical spectrum. Three main clinical forms are recognized: an infantile (symptomatic) form, a juvenile form, and a benign (asymptomatic) adult form. The infantile form can present with episodic vomiting, metabolic acidosis, hypoglycemia, altered consciousness, and seizures, often triggered by intercurrent illness or fasting. Some patients may also exhibit adrenal insufficiency-like symptoms, failure to thrive, and developmental delay. The juvenile form may present with growth delay and mild intellectual disability. The adult or benign form is often discovered incidentally when elevated triglyceride levels are found on routine blood testing — this is actually pseudohypertriglyceridemia, as some laboratory assays cannot distinguish glycerol from triglycerides. There is no specific cure for isolated glycerol kinase deficiency. Management is primarily supportive and includes avoidance of prolonged fasting, prompt treatment of metabolic crises with intravenous glucose and fluids, and monitoring for metabolic decompensation during illness. Dietary management with attention to adequate caloric intake may be recommended. Genetic counseling is important for affected families. It is essential to distinguish isolated GKD from the contiguous gene deletion syndrome involving the GK, DAX1 (NR0B1), and DMD genes, which results in a more severe phenotype including congenital adrenal hypoplasia and Duchenne muscular dystrophy.

Also known as:

Clinical phenotype terms— hover any for plain English:

Adrenocortical hypoplasiaHP:0008182
Inheritance

X-linked recessive

Carried on the X chromosome; typically affects males more than females

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

1 available

Crestor

rosuvastatin· iPR Pharmaceuticals, Inc.

As an adjunct to diet for the treatment of adults with hypertriglyceridemia

No actively recruiting trials found for Isolated glycerol kinase deficiency at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Isolated glycerol kinase deficiency community →

No specialists are currently listed for Isolated glycerol kinase deficiency.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources
Crestor(rosuvastatin)iPR Pharmaceuticals, Inc.

Travel Grants

No travel grants are currently matched to Isolated glycerol kinase deficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Isolated glycerol kinase deficiencyForum →

No community posts yet. Be the first to share your experience with Isolated glycerol kinase deficiency.

Start the conversation →

Latest news about Isolated glycerol kinase deficiency

No recent news articles for Isolated glycerol kinase deficiency.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Isolated glycerol kinase deficiency

What is Isolated glycerol kinase deficiency?

Isolated glycerol kinase deficiency (GKD), also known as hyperglycerolemia, is a rare X-linked metabolic disorder caused by mutations in the GK gene located on chromosome Xp21.2. Glycerol kinase is an enzyme that catalyzes the phosphorylation of glycerol to glycerol-3-phosphate, a key step in fat metabolism and gluconeogenesis. When this enzyme is deficient, glycerol accumulates in the blood (hyperglycerolemia) and is excreted in excess in the urine (glyceroluria). The condition primarily affects males, while females are typically carriers who may occasionally show mild symptoms. Isolated GKD

How is Isolated glycerol kinase deficiency inherited?

Isolated glycerol kinase deficiency follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.